Brookfield Asset Management Inc. Adaptive Biotechnologies Corp Transaction History

Brookfield Asset Management Inc.

  • $14 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Nov 16, 2022
BUY
$6.4 - $14.73 $1.23 Million - $2.83 Million
192,258 New
192,258 $1.56 Million
Q2 2022

Aug 15, 2022
BUY
$6.4 - $14.73 $911,897 - $2.1 Million
142,484 Added 286.26%
192,258 $1.56 Million
Q3 2020

Nov 16, 2020
BUY
$35.79 - $48.81 $1.78 Million - $2.43 Million
49,774 New
49,774 $2.42 Million

Others Institutions Holding ADPT

# of Institutions
202
Shares Held
146M
Call Options Held
68.8K
Put Options Held
42.5K
View Full List

About Adaptive Biotechnologies Corp

ADPT Quotes by TradingView
  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $849M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Brookfield Asset Management Inc. Portfolio

Follow Brookfield Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brookfield Asset Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email